Alentis Therapeutics
Pre-clinicalTHE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing our pipeline of anti-Claudin-1 antibody-drug conjugates (ADCs) and monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1 and […]
About
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing our pipeline of anti-Claudin-1 antibody-drug conjugates (ADCs) and monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1 and […]
Funding History
2Total raised: $172M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile